Clinical Trials

SRC8: A Randomized Phase III Trial of Doxorubicin + Pembrolizumab versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

Link : https://www.clinicaltrials.gov/ct2/show/NCT06422806
Status : RECRUITING
Population : mUPS - first line setting
Description : Dox + pembro vs. Dox
PI : A. Salawu
Centers Opened : PMH
Phase : III
IIST/Pharma :